The Effect of Geometrical Isomerism of 3,5-Dicaffeoylquinic Acid on Its Binding Affinity to HIV-Integrase Enzyme: A Molecular Docking Study

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Makola, Mpho M ^a   Dubery, Ian A ^a   Koorsen, Gerrit ^a   Steenkamp, Paul A ^a,b   Kabanda, Mwadham M ^c   Du Preez, Louis L ^d   Madala, Ntakadzeni E ^a  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

^b DSI CSIR Nanotechnology Innovation Centre   (South Africa)

^c NORTH WEST UNIVERSITY   (South Africa)

^d UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DICAFFEOYLQUINIC ACID; ANTIVIRUS AGENT; INTEGRASE; LYSINE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; BINDING AFFINITY; CIS TRANS ISOMERISM; DENSITY FUNCTIONAL THEORY; DNA INTEGRATION; ENZYME ACTIVE SITE; ISOMER; ISOMERISM; MOLECULAR DOCKING; PROTEIN PROTEIN INTERACTION;

EID: 84994391780     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/4138263     Document Type: Article

References (39)

1. M. Hill, G. Tachedjian, and J. Mak, "The packaging and maturation of the HIV-1 pol proteins," Current HIV Research, vol. 3, no. 1, pp. 73-85, 2005.
2. K. Kassahun, I. McIntosh, D. Cui et al., "Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme," Drug Metabolism and Disposition, vol. 35, no. 9, pp. 1657-1663, 2007.
3. D. J. McColl and X. Chen, "Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy," Antiviral Research, vol. 85, no. 1, pp. 101-118, 2010.
4. A. Engelman and P. Cherepanov, "Retroviral integrase structure and DNA recombination mechanism," Microbiology Spectrum, vol. 2, no. 6, pp. 1-22, 2014.
5. R. Craigie, "HIV integrase, a brief overview from chemistry to therapeutics," The Journal of Biological Chemistry, vol. 276, no. 26, pp. 23213-23216, 2001.
6. T. M. Jenkins, D. Esposito, A. Engelman, and R. Craigie, "Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking," The EMBO Journal, vol. 16, no. 22, pp. 6849-6859, 1997.
7. K. Zhu, M. L. Cordeiro, J. Atienza, W. Edward Robinson Jr., and S. A. Chow, "Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids," Journal of Virology, vol. 73, no. 4, pp. 3309-3316, 1999.
8. H. Tamura, T. Akioka, K. Ueno et al., "Anti-human immunodeficiency virus activity of 3,4,5-tricaffeoylquinic acid in cultured cells of lettuce leaves," Molecular Nutrition and Food Research, vol. 50, no. 4-5, pp. 396-400, 2006.
9. H. M. Heyman, F. Senejoux, I. Seibert, T. Klimkait, V. J. Maharaj, and J. J. M. Meyer, "Identification of anti-HIV active dicaffeoylquinic- and tricaffeoylquinic acids in Helichrysum populifolium by NMR-based metabolomic guided fractionation," Fitoterapia, vol. 103, pp. 155-164, 2015.
10. T. Satake, K. Kamiya, Y. An, T. Oishi, and J. Yamamoto, "The anti-thrombotic active constituents from Centella asiatica," Biological and Pharmaceutical Bulletin, vol. 30, no. 5, pp. 935-940, 2007.
11. A. Prasad, M. Singh, N. P. Yadav, A. K. Mathur, and A. Mathur, "Molecular, chemical and biological stability of plants derived from artificial seeds of Centella asiatica (L.) Urban-an industrially important medicinal herb," Industrial Crops and Products, vol. 60, pp. 205-211, 2014.
12. H. C. Kwon, C.M. Jung, C. G. Shin et al., "A new caffeoyl quinic acid from Aster scaber and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase," Chemical and Pharmaceutical Bulletin, vol. 48, no. 11, pp. 1796-1798, 2000.
13. Z. Hu, D. Chen, L. Dong, and W.M. Southerland, "Predictionof the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecularmodeling approach," Ethnicity and Disease, vol. 20, no. 1, pp. S145-S149, 2010.
14. M. M. Makola, P. A. Steenkamp, I. A. Dubery, M. M. Kabanda, and N. E. Madala, "Preferential alkali metal adduct formation by cis geometrical isomers of dicaffeoylquinic acids allows for efficient discrimination from their trans isomers during ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry," Rapid Communications in Mass Spectrometry, vol. 30, no. 8, pp. 1011-1018, 2016.
15. E. F. Healy, J. Sanders, P. J. King, and W. E. Robinson Jr., "A docking study of l-chicoric acidwith HIV-1 integrase," Journal of Molecular Graphics and Modelling, vol. 27, no. 5, pp. 584-589, 2009.
16. n analysis of the cis isomers of chlorogenic acids," Food Chemistry, vol. 106, no. 1, pp. 379-385, 2008.
17. H. Karaköse, R. Jaiswal, S. Deshpande, and N. Kuhnert, "Investigation of the photochemical changes of chlorogenic acids induced by ultraviolet light inmodel systems and in agricultural practice with Stevia rebaudiana cultivation as an example," Journal of Agricultural and Food Chemistry, vol. 63, no. 13, pp. 3338-3347, 2015.
18. J. Mc Conathy and M. J. Owens, "Stereochemistry in drug action," The Primary Care Companion to the Journal of Clinical Psychiatry, vol. 5, no. 2, pp. 70-73, 2003.
19. A. G. Tzakos, N. Naqvi, K. Comporozos et al., "The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme," Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 19, pp. 5084-5087, 2006.
20. F. Jamali, R. Mehvar, and F. M. Pasutto, "Enantioselective aspects of drug action and disposition: therapeutuc pitfalls," Journal of Pharmaceutical Sciences, vol. 78, no. 9, pp. 695-715, 1989.
21. N. J. Farrer, J.A. Woods, L. Salassa et al., "Apotent trans-diimine platinum anticancer complex photoactivated by visible light," Angewandte Chemie-International Edition, vol. 49, no. 47, pp. 8905-8908, 2010.
22. M. Fréneau, P. de Sainte Claire, N. Hoffmann et al., "Phototransformation of tetrazoline oxime ethers: photoisomerization vs. photodegradation," RSC Advances, vol. 6, no. 7, pp. 5512-5522, 2016.
23. M. J. Frisch, G. W. Trucks, H. B. Schlegel et al., Gaussian 09, Revision C.01, Gaussian, Inc, Wallingford, Conn, USA, 2009.
24. E. Krieger and G. Vriend, "YASARA view-molecular graphics for all devices-from smartphones to workstations," Bioinformatics, vol. 30, no. 20, pp. 2981-2982, 2014.
25. O. Trott and A. J. Olson, "Auto Dock VINA: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading," Journal of Computational Chemistry, vol. 31, no. 2, pp. 455-461, 2010.
26. M. L. Vueba, M. E. Pina, F. Veiga, J. J. Sousa, and L. A. E. B. De Carvalho, "Conformational study of ketoprofen by combined DFT calculations and Raman spectroscopy," International Journal of Pharmaceutics, vol. 307, no. 1, pp. 56-65, 2006.
27. S.A. DePriest, D. Mayer, C. B. Naylor, and G. R. Marshall, "3DQSAR of angiotensin-converting enzyme and thermolysin inhibitors: a comparison of CoMFA models based on deduced and experimentally determined active site geometries," Journal of the American Chemical Society, vol. 115, no. 13, pp. 5372-5384, 1993.
28. N. Nunthaboot, S. Pianwanit, V. Parasuk, S. Kokpol, and P. Wolschann, "Theoretical study on the HIV-1 integrase inhibitor 1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)-propenone (5CITEP)," Journal of Molecular Structure, vol. 844-845, pp. 208-214, 2007.
29. C. L. Padgett, A. P. Hanek, H. A. Lester, D. A. Dougherty, and S. C. R. Lummis, "Unnatural amino acid mutagenesis of the GABAA receptor binding site residues reveals a novel cation-π interaction between GABA and β2Tyr97," The Journal of Neuroscience, vol. 27, no. 4, pp. 886-892, 2007.
30. D. A. Dougherty, "The cation-π interaction," Accounts of Chemical Research, vol. 46, no. 4, pp. 885-893, 2013.
31. D. Esposito and R. Craigie, "HIV integrase structure and function," Advances in Virus Research, vol. 52, pp. 319-333, 1999.
32. 2+ ions on the interaction between 3,5-dicaffeoylquinic acid and HTLV-I integrase," Universitas Scientiarum, vol. 17, no. 1, pp. 5-15, 2012.
33. X.-W. Jiang, J.-P. Bai, Q. Zhang et al., "Caffeoylquinic acid derivatives from the roots of Arctium lappa L. (burdock) and their structure-activity relationships (SARs) of free radical scavenging activities," Phytochemistry Letters, vol. 15, pp. 159-163, 2016.
34. Y.-L. Chen, S.-T. Huang, F.-M. Sun et al., "Transformation of cinnamic acid from trans-to cis-form raises a notable bactericidal and synergistic activity against multiple-drug resistant Mycobacterium tuberculosis," European Journal of Pharmaceutical Sciences, vol. 43, no. 3, pp. 188-194, 2011.
35. W. Liu, X. Han, Y. Xiao et al., "Synthesis, photostability and bioactivity of 2,3-cyclopropanated abscisic acid," Phytochemistry, vol. 96, pp. 72-80, 2013.
36. R. Guimarães, L. Barros, M. Dueñas et al., "Infusion and decoction of wild German chamomile: bioactivity and characterization of organic acids and phenolic compounds," Food Chemistry, vol. 136, no. 2, pp. 947-954, 2013.
37. M. I. Dias, L. Barros, M. Dueñas et al., "Chemical composition of wild and commercial Achillea millefolium L. and bioactivity of themethanolic extract, infusion and decoction," Food Chemistry, vol. 141, no. 4, pp. 4152-4160, 2013.
38. T. Ramabulana, R. D. Mavunda, P. A. Steenkamp, L. A. Piater, I. A. Dubery, and N. E. Madala, "Perturbation of pharmacologically relevant polyphenolic compounds in Moringa oleifera against photo-oxidative damages imposed by gamma radiation," Journal of Photochemistry and Photobiology B: Biology, vol. 156, pp. 79-86, 2016.
39. M. I. Mhlongo, L. A. Piater, P. A. Steenkamp, N. E. Madala, and I. A. Dubery, "Metabolomic fingerprinting of primed tobacco cells provide the first evidence for the biological origin of cischlorogenic acid," Biotechnology Letters, vol. 37, no. 1, pp. 205-209, 2015.